BPP-II

General Information


DRACP ID  DRACP04800

Peptide Name   BPP-II

Sequence  MTLTG

Sequence Length  5

UniProt ID  Not available

PubChem CID  Not available

Origin  Immunomodulatory bursal-derived Pentapeptide-II

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C21H39N5O8S

Absent amino acids  ACDEFHIKNPQRSVWY

Common amino acids  T

Mass  59316

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  1

Net charge  0

Boman Index  307

Hydrophobicity  78

Aliphatic Index  78

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22184121

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




CancerPPD ID  3198

CancerPPD ID  3200

CancerPPD ID  3201

CancerPPD ID  3202

CancerPPD ID  3203

CancerPPD ID  3204

CancerPPD ID  3205

CancerPPD ID  3208

CancerPPD ID  3210

CancerPPD ID  3211

CancerPPD ID  3212

CancerPPD ID  3213

CancerPPD ID  3214

CancerPPD ID  3215

DRACP is developed by Dr.Zheng's team.